학술논문

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials
Document Type
Article
Author
Horsley, AlexanderNash, Edward F.Bakker, Marleenvan der Meer, RenskeMerkus, PetrusMajoor, ChristofMcCoy, KarenBillings, JoannePancham, KrishnaTolle, JamesQuick, BryonUluer, AhmetDiMango, EmilyRao, AdupaReyes, SantiagoKlingsberg, RossBarreto, CelesteOrtega, VictorWilley-Courand, DonnaSchwarz, CarstenSutharsan, SivagurunathanFischer, RainaldDavies, JaneDuckers, JamieDoe, SimonHeijerman, HarrySolomon, George M.Merlo, ChristianGriffonnet, JenniferPilewski, JosephDunitz, JordanSheikh, SabaRubenstein, Ronald C.Rosenbluth, Daniel B.Liou, TheodoreIndihar, MariaYonker, LaelNasr, SamyaBrown, Cynthia D.Sawicki, Gregory S.Ruddy, JenniferGarcia, BryanBraun, AndrewGifford, Alex H.Mehdi, NighatTupayachi Ortiz, MariaJain, RakshaCalimano, Francisco J.Johannes, JimmyDaines, Cori L.Fullmer, JasonMermis, JoelBarrios, ChristopherLy, NgocCasserly, Brian P.Eisenmann, StephanHebestreit, HelgeKiefer, AlexanderMacGregor, GordonPeckham, DanielLedson, MartinVan Braeckel, EvaMcElvaney, Noel GerardMcKone, EdwardPlant, BarryBurr, LucySmith, Daniel J.Middleton, PeterWilson, JohnUluer, Ahmet ZAzevedo, PilarIndihar, VeronicaKeating, ClaireMall, Marcus AMcKone, Edward FRamsey, Bonnie WRowe, Steven MRubenstein, Ronald CTaylor-Cousar, Jennifer LTullis, ElizabethYonker, Lael MChu, ChenghaoLam, Anna PNair, NitinSosnay, Patrick RTian, SimonVan Goor, FredrickViswanathan, LakshmiWaltz, DavidWang, Linda TXi, Yingmei
Source
In The Lancet Respiratory Medicine June 2023 11(6):550-562
Subject
Primary Research
Articles
Language
ISSN
2213-2600